切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2025, Vol. 11 ›› Issue (02) : 125 -129. doi: 10.3877/cma.j.issn.2096-1537.2025.02.004

年度进展

体外生命支持:2024 年度进展与展望
侯晓彤1,(), 王粮山1, 王可心1   
  1. 1. 100029 北京,首都医科大学附属北京安贞医院成人心脏危重症中心
  • 收稿日期:2025-03-09 出版日期:2025-05-28
  • 通信作者: 侯晓彤

Extracorporeal life support:progress and prospects in 2024

Xiaotong Hou1,(), Liangshan Wang1, Kexin Wang1   

  1. 1. Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China
  • Received:2025-03-09 Published:2025-05-28
  • Corresponding author: Xiaotong Hou
引用本文:

侯晓彤, 王粮山, 王可心. 体外生命支持:2024 年度进展与展望[J/OL]. 中华重症医学电子杂志, 2025, 11(02): 125-129.

Xiaotong Hou, Liangshan Wang, Kexin Wang. Extracorporeal life support:progress and prospects in 2024[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(02): 125-129.

本文回顾了2024 年体外生命支持领域的关键研究进展,主要聚焦于患者选择、管理策略优化、并发症防控以及技术创新等多个维度。众多研究成果为临床医师提供了更加精准、谨慎的治疗决策依据,同时为未来在个体化治疗、多学科协作和技术创新等方向的研究指明了新的方向。

This article reviews the key research advances in the field of extracorporeal life support in 2024,with a primary focus on patient selection,optimization of management strategies,complication prevention,and technological innovation across multiple dimensions.Numerous research findings have provided clinical practitioners with more precise and cautious guidance for treatment decision-making,while also pointing to new directions for future studies in personalized therapy,multidisciplinary collaboration,and technological innovation.

表1 ECMO 在心原性休克中应用的关键研究比较
1
Ostadal P,Rokyta R,Karasek J,et al.Extracorporeal membrane oxygenation in the therapy of cardiogenic shock:1-year outcomes of the multicentre,randomized ECMO-CS trial [J].Eur J Heart Fail,2025,27(1):30-36.
2
Desch S,Zeymer U,Akin I,et al.Routine extracorporeal life support in infarct-related cardiogenic shock:1-year results of the ECLSSHOCK trial [J].Eur Heart J,2024,45(39):4200-4203.
3
Low C,Ling RR,Ramanathan K,et al.Extracorporeal cardiopulmonary resuscitation versus conventional CPR in cardiac arrest:an updated meta-analysis and trial sequential analysis [J].Crit Care,2024,28(1):57.
4
Scquizzato T,Calabrò MG,Franco A,et al.Extracorporeal cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest:10-year experience in a metropolitan cardiac arrest centre in Milan,Italy [J].Resusc Plus,2024,17:100521.
5
Viersen VA,Greuters S,Korfage AR,et al.Hyperfibrinolysis in out of hospital cardiac arrest is associated with markers of hypoperfusion [J].Resuscitation,2012,83(12):1451-1455.
6
Wada T,Gando S,Ono Y,et al.Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest [J].Thromb J,2016,14:43.
7
Magomedov A,Kruse JM,Zickler D,et al.Association of hyperfibrinolysis with poor prognosis in refractory circulatory arrest:implications for extracorporeal cardiopulmonary resuscitation [J].Br J Anaesth,2024,133(3):500-507.
8
Fu HY,Chen YS,Yu HY,et al.Emergent coronary revascularization with percutaneous coronary intervention and coronary artery bypass grafting in patients receiving extracorporeal cardiopulmonary resuscitation [J].Eur J Cardiothorac Surg,2024,66(2):ezae290.
9
Ezad SM,Ryan M,Barrett N,et al.Left ventricular unloading in patients supported with veno-arterial extra corporeal membrane oxygenation; an international EuroELSO survey [J].Perfusion,2024,39(1_suppl):13S-22S.
10
Zhang H,Wang T,Wang J,et al.Different strategies in left ventricle unloading during venoarterial extracorporeal membrane oxygenation:a network meta-analysis [J].Int J Cardiol Heart Vasc,2024,54:101506.
11
Inglis SS,Rosenbaum AN,Rizzo SA,et al.Novel left ventricular unloading strategies in patients on peripheral venoarterial extracorporeal membrane oxygenation support [J].ASAIO J,2024,70(5):396-403.
12
Lüsebrink E,Binzenhöfer L,Hering D,et al.Scrutinizing the role of venoarterial extracorporeal membrane oxygenation:has clinical practice outpaced the evidence? [J].Circulation,2024,149(13):1033-1052.
13
Wang K,Wang L,Ma J,et al.Intra-aortic balloon pump after VAECMO reduces mortality in patients with cardiogenic shock:an analysis of the Chinese Extracorporeal Life Support Registry [J].Crit Care,2024,28(1):394.
14
Premraj L,Brown A,Fraser JF,et al.Oxygenation during venoarterial extracorporeal membrane oxygenation:physiology,current evidence,and a pragmatic approach to oxygen titration [J].Crit Care Med,2024,52(4):637-648.
15
Burrell A,Bailey MJ,Bellomo R,et al.Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation [J].Intensive Care Med,2024,50(9):1470-1483.
16
Chandel A,Fabyan KD,Mendelsohn S,et al.Prevalence and survival of prolonged venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome:an analysis of the Extracorporeal Life Support Organization Registry [J].Crit Care Med,2024,52(6):869-877.
17
Bunge J,Mariani S,Meuwese C,et al.Characteristics and outcomes of prolonged venoarterial extracorporeal membrane oxygenation after cardiac surgery:the post-cardiotomy extracorporeal life support(PELS-1) cohort study [J].Crit Care Med,2024,52(10):e490-e502.
18
Martucci G,Giani M,Schmidt M,et al.Anticoagulation and bleeding during veno-venous extracorporeal membrane oxygenation:insights from the PROTECMO study [J].Am J Respir Crit Care Med,2024,209(4):417-426.
19
Mansour A,Berahou M,Odot J,et al.Antithrombin levels and heparin responsiveness during venoarterial extracorporeal membrane oxygenation:a prospective single-center cohort study [J].Anesthesiology,2024,140(6):1153-1164.
20
Xu P,Zhang Y,Guo J,et al.A single-domain antibody targeting factorⅫ inhibits both thrombosis and inflammation [J].Nat Commun,2024,15(1):7898.
21
中国医师协会体外生命支持专业委员会.体外膜氧合患者脑监测中国专家共识 [J].中华医学杂志,2024,104(9):662-673.
22
Cho SM,Hwang J,Chiarini G,et al.Neurological monitoring and management for adult extracorporeal membrane oxygenation patients:Extracorporeal Life Support Organization consensus guidelines [J].Crit Care,2024,28(1):296.
23
Cho SM,Khanduja S,Wilcox C,et al.Clinical use of bedside portable ultra-low-field brain magnetic resonance imaging in patients on extracorporeal membrane oxygenation:results from the multicenter SAFE MRI ECMO study [J].Circulation,2024,150(24):1955-1965.
24
Haus M,Foltan M,Philipp A,et al.Neutrophil extracellular traps -a potential trigger for the development of thrombocytopenia during extracorporeal membrane oxygenation [J].Front Immunol,2024,15:1339235.
25
Swain L,Bhave S,Qiao X,et al.Novel role for cardiolipin as a target of therapy to mitigate myocardial injury caused by venoarterial extracorporeal membrane oxygenation [J].Circulation,2024,149(17):1341-1353.
26
Goh T,Gao L,Singh J,et al.Platelet adhesion and activation in an ECMO thrombosis-on-a-chip model [J].Adv Sci (Weinh),2024,11(30):e2401524.
[1] 郑树森. 肝胆胰手术的技术创新[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(02): 0-0.
[2] 陈华文, 仇成华, 李晓青, 谢鹏. 冠状动脉旁路移植术后手术部位感染风险预测模型及管理策略[J/OL]. 中华实验和临床感染病杂志(电子版), 2022, 16(01): 39-46.
[3] 张海霞, 林兆霞, 张志云, 何明, 万钢. 2007年至2018年某传染病医院医护人员血源性职业暴露状况分析与管理策略[J/OL]. 中华实验和临床感染病杂志(电子版), 2019, 13(03): 227-233.
[4] 孙晓容, 张巧, 吴红梅, 李长桂. COVID-19疫情期间非定点医院呼吸与危重症医学科管理策略[J/OL]. 中华肺部疾病杂志(电子版), 2020, 13(04): 575-576.
[5] 袁思依, 隆云, 池熠, 苏龙翔, 程卫, 赵华, 刘旺林, 张超纪, 马国涛, 黄慧, 何怀武. 长时程ECMO生命支持管理策略临床应用的单中心经验[J/OL]. 中华重症医学电子杂志, 2025, 11(01): 65-71.
[6] 许浩, 罗亮. 体外膜肺氧合支持期间新发感染的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 292-297.
[7] 李文哲, 潘鹏飞, 崔建, 于湘友. 体外生命支持技术临床应用的伦理学问题[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 97-101.
[8] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
[9] 王光林, 刘广杰, 胡旭华, 王飞飞, 张建锋, 樊少青, 孟泽松, 李保坤, 张娟, 王贵英. 新型冠状病毒肺炎疫情下结直肠癌患者的管理策略[J/OL]. 中华临床医师杂志(电子版), 2021, 15(06): 401-406.
[10] 马宁, 汤福鑫, 于洪燕, 周太成, 陈双. 新型冠状病毒疫情下食管裂孔疝患者的临床管理策略[J/OL]. 中华胃食管反流病电子杂志, 2020, 07(02): 105-109.
[11] 岳茂兴. 突发事件应急救援与处置关键技术创新研发与应用[J/OL]. 中华卫生应急电子杂志, 2020, 06(05): 320-320.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?